John Mendlein

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• University of California, Los Angeles9.4%
• Bristol-Myers Squibb (United States)9.2%
• aTyr Pharma (United States)8.5%
• Harvard University8.3%
• Shanghai Jiao Tong University6.9%
• Karolinska Institutet6.7%
• Other50.9%

Fields

• Biochemistry, Genetics and Molecular Biology50.6%
• Medicine40.9%
• Immunology and Microbiology3.8%
• Pharmacology, Toxicology and Pharmaceutics1.3%
• Computer Science0.8%
• Materials Science0.8%
• Other1.7%

Topics

• Hematopoietic Stem Cell Transplantation12.5%
• RNA modifications and cancer9.4%
• RNA and protein synthesis mechanisms9.1%
• RNA Research and Splicing8.4%
• Epigenetics and DNA Methylation7.8%
• Ion Transport and Channel Regulation7.8%
• Other45%